LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q4 2024 Earnings Call Transcript March 19, 2025
LENZ Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $-0.42.
Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year End 2024 Financial Results Conference Call. This time all participants are in a listen-only mode. Following prepared remarks from the management, we will conduct a question-and-answer session where instructions...
